These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14754648)

  • 1. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study.
    Hollar CB; Jorizzo JL
    J Dermatolog Treat; 2004 Jan; 15(1):35-9. PubMed ID: 14754648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical tacrolimus and resistant skin lesions of dermatomyositis].
    Peyrot I; Sparsa A; Loustaud-Ratti V; Liozon E; Vidal E; Bonnetblanc JM; Bedane C
    Rev Med Interne; 2006 Oct; 27(10):730-5. PubMed ID: 16987569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Tacrolimus Ointment Alone versus in Combination with Microneedling for Refractory Stable Vitiligo.
    Kiran A; Khan S; Ahmed N; Ali M
    J Coll Physicians Surg Pak; 2024 May; 34(5):514-517. PubMed ID: 38720208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
    Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases.
    Böhm M; Gaubitz M; Luger TA; Metze D; Bonsmann G
    Dermatology; 2003; 207(4):381-5. PubMed ID: 14657631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients.
    García-Doval I; Cruces M
    Dermatology; 2004; 209(3):247-8. PubMed ID: 15459546
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.
    Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD
    BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.
    Braza TJ; DiCarlo JB; Soon SL; McCall CO
    Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
    Laeijendecker R; Tank B; Dekker SK; Neumann HA
    Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
    Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
    Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study.
    Zonneveld IM; Rubins A; Jablonska S; Dobozy A; Ruzicka T; Kind P; Dubertret L; Bos JD
    Arch Dermatol; 1998 Sep; 134(9):1101-2. PubMed ID: 9762021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.